BRCA2 and complete blood cell count: The subgroup analysis revealed that RRSO was not associated with CBC risk reduction in BRCA1 carriers alone (RR 0.85, 95%CI 0.59–1.24) or BRCA2 carriers alone (RR 0.35, 95%CI 0.07–1.74).